Bristol Myers to acquire Karuna Therapeutics for $14 billion
HQ Team December 23, 2023: Bristol Myers Squibb will buy US-based biotech company, Karuna Therapeutics for $14 billion to expand its neuroscience portfolio,.
Drugs
Health
Pharma